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a b s t r a c t 
Whole body exposure to low linear energy transfer (LET) ionizing radiations (IRs) damages vital intracellular 
bio-molecules leading to multiple cellular and tissue injuries as well as pathophysiologies such as inﬂamma- 
tion, immunosuppression etc. Nearly 70% of damage is caused indirectly by radiolysis of intracellular water 
leading to formation of reactive oxygen species (ROS) and free radicals and producing a state of oxidative 
stress. The damage is also caused by direct ionization of biomolecules. The type of radiation injuries is de-
pendent on the absorbed radiation dose. Sub-lethal IR dose produces more of DNA base damages, whereas 
higher doses produce more DNA single strand break (SSBs), and double strand breaks (DSBs). The Nrf2-ARE 
pathway is an important oxidative stress regulating pathway. The DNA DSBs repair regulated by MRN com- 
plex, immunomodulation and inﬂammation regulated by HMGB1 and various types of cytokines are some of 
the key pathways which interact with each other in a complex manner and modify the radiation response. 
Because the majority of radiation damage is via oxidative stress, it is essential to gain in depth understanding
of the mechanisms of Nrf2-ARE pathway and understand its interactions with MRN complex, HMGB1 and 
cytokines to increase our understanding on the radiation responses. Such information is of tremendous help 
in development of medical radiation countermeasures, radioprotective drugs and therapeutics. Till date no 
approved and safe countermeasure is available for human use. This study reviews the Nrf2-ARE pathway and 
its crosstalk with MRN-complex, HMGB1 and cytokines (TNF- α, IL-6, IFN- γ etc.). An attempt is also made 
to review the modiﬁcation of some of these pathways in presence of selected antioxidant radioprotective 
compounds or herbal extracts. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). Abbreviations: IR, ionizing radiation; LET, linear energy transfer; ROS, reactive oxy- 
en species; DSB, double strands break; DDR, DNA damage response; SOD, superoxide 
ismutase; SSBs, single strand DNA breaks; . OH, hydroxyl radical; ARE, antioxidant 
esponse element; GPx, glutathione peroxidase; GSH, glutathione (reduced); MRN, 
re11, Rad50 and Nbs1 subunits; NADPH, nicotinamide adenine dinucleotide phos- 
hate; NES, nuclear export sequence; Keap1, Kelch like ECH associated protein 1; DGR, 
ouble glycine repeats; PKC, protein kinase C; GSK-3 β, glycogen synthase kinase 3 
eta; t-BHQ, tert butyl hydroquinone; Bcl-2, B cell lymphoma-2 protein; NHEJ, non- 
omologous end joining; HR, homologous recombination; RIF, radiation induced foci; 
TM, ataxia telangiectasia mutagenesis; Chk-2, checkpoint kinase-2 protein; HMGB1, 
igh mobility group Box 1; RAGE, receptor for advance glycation end products; MRP, 
ultidrug resistance protein; GM-CSF, granulocytes macrophages colony stimulating 
actor; TRAIL, TNF related apoptosis inducing ligand; VEGF, vascular endothelial growth 
actor; FGF, ﬁbroblast growth factor; TWEAK, tumour necrosis factor weak inducer of 
poptosis; AP1, activator protein-1; RNS, reactive nitrogen species; NLS, nuclear lo- 
alization sequence; DAMP, death associated molecular pattern; bFGF, basal ﬁbroblast 
rowth factor; VEGF, vascular endothelial growth factor; VSMC, vascular smooth mus- 
le cells; FGF2, ﬁbroblast growth factor-2; CBP, CREB-binding protein; MDA, malondi- 
ldehyde; MIP, macrophages inﬂammatory proteins. 
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Ionizing radiation (IR) is being increasingly used in medicine for 
diagnosis and therapy, industry and warfare. The uncontrolled ex- 
posure of normal biological systems to IR causes various unwanted 
biological effects, which are often dependent on IR dose. To counter 
such effects there is an imminent need for development of medical 
radiation countermeasures. After the World War II, a large number 
of chemical agents were reported to have radio-protective proper- 
ties in pre-clinical studies, yet none was found suitable for human 
use. Development of a safe, protective and effective medical radia- 
tion countermeasure, therefore, remains a global challenge till date. 
Understanding more about the mechanisms of radiation injuries and 
interactions between various IR induced pathways, is very important of Nuclear Medicine and Allied Sciences, Defence Research Development Organisa- 
tion (Grant Sponser), Brig SK Mazumdar Marg, Delhi -110054, India. Phone: + 91 11 
23970081. 
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 to meet these challenges. Total body exposure to IR results in multiple
inter- or intra-cellular lesions. The damage caused by IR is primarily
by two mechanisms. The energy may be directly deposited into the
biomolecules (nucleic acids, proteins, lipids etc.) resulting in disrup-
tion of their chemical bonds. On the other hand, energy may cause
radiolysis of intracellular water molecules leading to production of a
ﬂux of multiple reactive oxygen species (ROS) and free radicals which
damage the cellular biomolecules. The high LET IR (e.g. α-particles,
heavy ions) causes most of the damage by direct deposition of energy
into the biomolecules. The low LET IR (e.g. X-rays, γ-rays) causes
most of the damages by ionization of intracellular water molecules.
The cell generally has 70–80% water content. Therefore, the low LET
IR causes 70–80% of damage by generating ROS and free radicals.
Superoxide anion (O 2 
. −), hydroxyl radical ( . OH), hydrogen peroxide
(H 2 O 2 ), and singlet oxygen ( 
1 O 2 ) are some of the reactive oxygen
species which cause multiple lesions such as oxidation of membrane
lipids, amino acids, modiﬁcation of thiols and DNA damage. The low
LET IR is deeply penetrating radiations and therefore, pose a greater
challenge. The majority of DNA damage caused by sub-lethal doses of
low LET IR is the DNA base modiﬁcation and base damage. At higher
doses, besides DNA base modiﬁcation and base damage, more com-
plex DNA lesions such as DNA single strand breaks (SSBs), double
strand breaks (DSBs) and other clustered DNA lesions are observed
[ 1 ]. In general, the exposure of cultured mammalian cells to 1 Gy of IR
can generate approximately 20–40 DSBs as well as approximately 10 3
SSBs and base damages in DNA [ 2 ]. IR injuries to lipids and proteins
result in membrane damage and cell disruption, leading to inﬂamma-
tion and immunomodulation. Altered levels of various cytokines such
as TNF- α [ 3 ], IL-6, IFN- γ as well as of damage associated molecular
pattern such as HMGB1 are reported [ 4 ]. 
Under normal physiological conditions, the intracellular ROS are
generally produced as a by-product of mitochondrial electron trans-
port chain and a delicate balance is maintained between the level
of oxidative species generated and the inherent antioxidant defence
mechanisms resulting in a state of ‘redox homeostasis ’ . The physio-
logically normal level of ROS helps in cellular growth and regulating
multiple signalling pathways [ 5 ]. The increased ﬂux of ROS, after ex-
posure to low LET IR, disturbs the normal redox homeostasis to favour
a state of “oxidative stress”, where the intracellular concentration of
ROS far exceeds the balancing capacity of antioxidant defence mecha-
nisms [ 6 ]. The IR induced oxidative stress leads to increased apoptosis
[ 7 , 8 ] as well as multiple pathologies, such as necrosis [ 9 ], inﬂam-
mation, aging [ 10 , 11 ], ischemic injuries, neurodegenerative diseases,
rheumatoid arthritis, and cancer [ 12 ]. The translesional synthesis of
nucleic acids, disturbances in cell cycle progression, accumulation
of unrepaired damage, necrosis mediated activation of inﬂamma-
tory pathways etc., are some of the underlying mechanisms of these
pathologies. To maintain the intracellular state of redox homeosta-
sis, the intracellular antioxidants act as ﬁrst line of defence. Several
antioxidant enzymes such as superoxide dismutase (SOD), catalase,
heme oxygenase (HO-1), NAD(P)H oxidoreductase quinone-1 (NQO-
1), glutathione (GSH), glutathione S-transferase subunit (GSTs), and
glutathione peroxidase (GPx) act as primary scavengers of ROS and
free radicals [ 13 ]. Certain non-enzymatic chemical and biochemical
antioxidant species (ascorbic acid, alpha tocopherol, polyphenols etc.)
act to neutralize the ROS by donating the electrons. The ascorbic acid
(vitamin C) is a natural water soluble essential micronutrient. It pri-
marily scavenges ROS and their derivatives, to protect the oxidation
of intracellular macromolecules [ 14 ]. The α-tocopherol (vitamin E) is
an important lipid soluble vitamin and another strong antioxidant,
which acts as a neutralizing agent for peroxyl radicals to form lipid
peroxides and tocopheryl radicals. Fig. 1 schematically represents
these events. 
Polyphenols are the dietary supplements which act as scavenger
of ROS, enzyme modulator and metal chelators [ 15 –17 ]. The com-
mon phenolic components are resveratrol, gallic acid, anthocyanin,catechin, myricetin, quercetin etc. At molecular level the role of the
transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2),
is well recognized in modulating antioxidant response. The mecha-
nisms underlying the Nrf2-antioxidant response element (ARE) path-
way are being actively investigated. It is very important to understand
the Nrf2-ARE pathway and its interactions with the various other
molecular pathways that are affected by IR. This study reviews the
crosstalk between the Nrf2-ARE pathways, MRN-complex regulated
DNA damage repair pathway, HMGB1 and cytokine mediated inﬂam-
mation and immune pathways. An attempt is also made to review
the modiﬁcation of these pathways by selected radiomodifying plant
extracts and antioxidant compounds. 
Keap1-Nrf2-ARE pathway 
The transcription factor Nrf2, also known as heme binding protein
1 (HEBP1), is a potent transcriptional activator and plays a central role
in inducing the expression of many cytoprotective genes in response
to oxidative and electrophilic stress. Nrf2 is encoded by the Nfe2l2
gene located on chromosome 2 in humans. Theoretically, the molecu-
lar weight of Nrf2 is 66 kDa [ 18 ]. Nrf2 was ﬁrst identiﬁed in Drosophila
cap ‘ n ’ collar protein form, where this gene is required for labial and
mandibular development [ 19 ]. Using the tandom repeats of nuclear
factor like erythroid factor-2 (NF-E2) / activator protein-1 (AP1) of the
β-globulin locus as a recognition site probe, two NF-E2 related pro-
teins, Nrf1 [ 20 ] and Nrf2 [ 21 ], were identiﬁed. Nrf2 contained leucine
zipper motif and had N-terminal acidic domain (rich in glutamic and
aspartic acid), which could potentially function as an acidic trans-
activation domain. The homologous recombination mutational study
on Nrf1 disrupted mice showed lethality due to anaemic condition
of erythroid cells and fatal liver abnormalities. Nrf1 was, therefore,
proposed to be essential for development because of its direct role
in erythropoiesis. In the absence of adequate studies with Nrf2, the
early reports suggested that Nrf2 was dispensable for growth and
development [ 22 ]. However, later studies proposed that Nrf2 played
a key role in regulating the expression of cytoprotective genes un-
der xenobiotic stress [ 23 ]. A common binding motif of Nrf1 and Nrf2
on to hARE sequence driven NQO-1 gene was reported. Subsequent
studies demonstrated that expression of GSTs, NQO-1 enzymes were
markedly reduced in liver and intestine of mice which had disrupted
Nrf2 gene [ 24 ]. Such animals showed extreme sensitivity towards ox-
idative stress which explained the critical role of Nrf2 in cell survival
and growth. 
Regulation of Nrf2-ARE pathway 
Nrf2, in association with small Maf and Jun protein family, forms
an upstream transcriptional complex [ 25 –27 ]. This heterodimer state
of Nrf2 binds to the ARE sequence of DNA and regulates ARE-driven
genes that encode for detoxiﬁcation enzymes as well as antioxidant
proteins to augment the cellular ﬁrst line defense system against
oxidative stress [ 28 , 29 ]. ARE was initially identiﬁed as electrophilic
response element (EpRE) in the promoter region of the mouse GSTa1
gene [ 30 ]. ARE in association with Nrf2 activates transcription of many
downstream genes such as NQO-1, GST, UDP-glucosyl transferase 1-
Ab, glutamate cysteine ligase (Gclc), HO-1, thioredoxin reductase-1
(TXNRD1), thioredoxin, and ferratin-12. 
Under normal redox conditions, Nrf2 is present in the cell cyto-
plasm and promotes only basal level expression of cytoprotective
enzymes. Nrf2 acts as a transcription activator when transferred in-
side the nucleus. The Nrf2 has two kinds of binding partners, (a)
a cytoplasm repressor Kelch like ECH associated protein 1 (Keap1)
which strictly regulates Nrf2 stabilization in cell cytoplasm under
a normal redox state [ 24 ], and (b) ARE sequence, which is an up-
stream binding enhancer element of cytoprotective genes present in
the nucleus [ 31 ]. The Keap1 acts as a cytoplasmic repressor of Nrf2.
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Fig. 1. Schematic presentation of ROS mediated lipid peroxidation (LPx) chain reaction. The ﬁgure also shows the formation of highly reactive lipid peroxyl radicals (LPO . ) such as 
malondialdehyde (MDA) and 4-hydroxy-2( E )-nonenal (4HNE); as well as the inﬂuence of anti-oxidants on the LPx chain reactions. Ascorbic acid (vitamin C) and alpha-tocopherol 
(vitamin E) neutralize LPO . and act as antioxidants. Vitamin C serves dual role of pro-oxidant and antioxidant. As a pro-oxidant, the vitamin C catalyses conversion of lipid 
hydroperoxides (LOOH) into toxic LPO . . The toxic LPO . can damage the macromolecules (DNA, RNA, proteins) and may initiate cytotoxic, genotoxic and inﬂammatory reactions. 
The anti-oxidant property of vitamin C helps to prevent the interaction of lipid peroxidation products with the macromolecules (DNA, RNA, proteins) by converting them into 
unreactive conjugate of vitamin C-LPO products. Vitamin C also helps in the regeneration of α-tocopherol (vitamin E) through redox reaction. Vitamin C donates electron to 
tocopheryl radical (vitamin-E–O . ) and therefore, helps in maintaining the intracellular concentration of reduced tocopherol. 
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sn the cytoplasm, the Keap1–Nrf2 complex is ubiquitinated by the 
ullin3 (Cul3)–Keap1 ubiquitin ligase complex until degraded in the 
roteasome [ 32 –34 ]. Keap1, because of ubiquitin E3 ligase domain in 
ts structural composition, regularly maintains the basal expression of 
rf2 in the cytoplasm by polyubiqutination. Further, Keap1 also helps 
n transportation of Nrf2 to proteasomes in the cell for degradation 
nd recycling. So far, Keap1 has been identiﬁed in human, rat as well 
s mouse [ 24 , 35 , 36 ]. 
Structure analysis of Nrf2 showed that it has basic leucine zip- 
er (bZip) motif of cap ‘ n ’ collar protein family. Nrf2 comprises six 
ighly conserved regions called Nrf2-ECH homology (Neh) domains 
 37 –39 ]. Molecular studies of Nrf2 revealed that, the N-terminal Neh2 
omain contains seven lysine (Lys) residues for ubiquitin conjugation 
n the Keap1 binding site i.e. Kelch domain [ 24 ]. Fig. 2(A) schemati- 
ally shows the structure and domain of Nrf2. 
It was demonstrated that murine Keap1 comprised 624 amino 
cids and showed approximately 95% structural identity between 
ouse and human [ 40 , 41 ]. Keap1 acquires as much importance as 
rf2 in oxidative stress studies because it has parallel functioning 
owards regulation of Nrf2. Keap1 holds Neh2 domain of Nrf2 (com- 
rising low and high afﬁnity motifs) within the cytoplasm by its Kelch 
epeats domain at C-terminal, as shown in Fig. 2(B) . The N-terminal 
TB / POZ (stands for Bric a Bra ˇc, trantrack, broad complex / Pox virus 
inc ﬁnger) domain forms homodimers that enables Keap1 to interact 
ith Nrf2. Under normal redox condition, Nrf2 degradation is regu- 
ated by Keap1 BTB domain because it has a Cul3–E3 ligase binding site 
hat leads to Nrf2 ubiquitination and degradation via a proteasome 
athway. A key distinguishing feature of Keap1 is that it contains high 
umber of cysteine (Cys) residues. Murine Keap1 has 25 cys residues 
hereas human Keap1 has 27 cys residues [ 42 , 43 ]. 
It is important to understand the mechanisms by which Keap1 
enses the normal and oxidative stress conditions, which in turn regulate the Nrf2 suppression / repression process. Keap1 is a cyto- 
skeletal thiols rich protein. Mass spectrometry studies showed that 
Keap1 contained three important cysteine residues i.e., Cys 151, Cys 
273, and Cys 288, which undergo thiols modiﬁcation upon exposure 
to electrophilic / oxidative stress [ 44 ]. Modiﬁcation of thiols residues 
lead to the loss of E3 ligase ubiquitin activity (mediated via a ubiquitin 
pathway) as well as changes in the active site conformation of Cul3–
E3 ligase complex. In turn, Cul3–E3 complex detaches from Keap1 
and does not allow Nrf2 degradation, resulting in the stabilization of 
Nrf2 within the cytoplasm. The modiﬁed cysteine residues of Keap1 
sense the oxidative environment within the cell, which further affect 
the expression of nuclear export sequence (NES) on Keap1. The cyto- 
plasmic position of Keap1–Nrf2 is regulated by NES, which remains 
unmodiﬁed in the normal redox state. Under oxidative stress condi- 
tions, NES is modiﬁed, resulting in the loose association of Nrf2–Keap1 
[ 45 –47 ]. The amino acid 301-LVKIFEELTL-310 in hKeap1 was demon- 
strated to be a NES. The Keap1 mutant with both L308 / A and L310 / A 
substitution was unable to locate itself into the cytoplasm [ 48 ]. These 
studies suggested that under unstressed conditions, the signals from 
NES of Keap1 maintained the Keap1 dimer in association with Nrf2 in 
the cytoplasm. Further, the Keap1–Cul3 E3 ligase complex dependent 
ubiquitination process keeps degrading the Nrf2 continuously. 
The mechanisms by which “Keap1-actin cytoskeletal protein”
helps in retaining the Nrf2 into the cytoplasm, as well as those by 
which Keap1 releases the Nrf2 into the nucleus during oxidative stress 
are very important to understand. The interaction of Keap1–Kelch re- 
peats with Neh2 domain of Nrf2 alone is not sufﬁcient to localize 
Nrf2 into the cytoplasm. A confocal laser microscopic immunohisto- 
chemical study demonstrated the presence of actin cytoskeleton on 
the Keap1 structure [ 49 ]. The Keap1–Kelch repeats [also known as 
double glycine repeats (DGR)] have extreme β-propeller sheets con- 
formation that helps in binding with the ﬁlamentous actin (F-actin) 
Anuranjani, M. Bala / Redox Biology 2 (2014) 832–846 835 
Fig. 2(A). Schematicpresentation ofNrf2 structure,which consists six highly conserved regions calledneh (Nrf2-ECHhomology) domains. TheNMRstructural analysis demonstrated 
that Neh2 region of Nrf2 is ﬂanked by low afﬁnity DLG motif and high afﬁnity ETGE motif in α-helix conformation. The DLG motif is conserved among members of the CNC-bZip 
family members. The ETGE motif of Neh2 possess strong binding afﬁnity towards Keap1–Kelch domain [ 37 ]. Katoh et al. [ 38 ] demonstrated that Neh4 and Neh5 domains are two 
independent domains, which are rich in acidic residue and interact with CREB-binding protein (CBP). The Neh6 domain is indispensable. The Neh1 domain of Nrf2 allows for binding 
and heterodimerization with small Maf proteins within the nucleus. This modiﬁed complex of Nrf2 binds on upstream region of ARE sequence of DNA, under oxidative / electrophilic 
stress conditions. The C-terminal Neh3 is indispensable for transcriptional activity. To initiate the transcriptional activity Neh3 recruits chromo domain helicase DNA binding 
protein-6 (CHD6) [ 39 ], which is a chromatin remodelling enzyme and a DNA dependent ATPase associated with RNA polymerase II during transcription initiation and elongation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 proteins. The DGR domain of Keap1 directly holds the Nrf2 on one
side and actin ﬁlaments on the other side. The actin ﬁlaments are
distributed in the perinuclear region in the cytoplasm. The study on
Drosophila Kelch repeats proteins (KREP) demonstrated that binding
of F-actin regulated the KREP function as a substrate adaptor [ 50 ]. In
another experimental study, Kang et al. [ 51 ] used an actin stabilizing
agent “Phalloidin” that prevented actin ﬁlament depolymerization
under oxidative conditions leading to persistence of actin ﬁlaments
into the cytoplasm, and thereby, prevented the release of Nrf2 from
Keap1–Kelch binding or its translocation into the nucleus. Thus, actin
ﬁlamentous cytoskeleton provided an effective holding to Keap1–
Kelch proteins in the cytoplasm under redox state of cell which was
depolymerized under oxidative / electrophilic stress [ 49 ]. 
To understand the Nrf2 stabilization and translocation into the nu-
cleus under increased oxidative stress, a number of scientiﬁc studies
were performed [ 52 –62 ]. These studies suggested the participation of
interlinked signalling pathways and coordinated cellular responses.
Under oxidative stress conditions the homodimerization of Keap1 is
disrupted and the locking site on the Kelch repeats proteins of Keap1 is
no longer available for binding to the Nrf2–Neh2 domain. In addition,
there is weakening of the association of Keap1–Nrf2 binding complex.
Continuous accumulation of ROS and reactive nitrogen species (RNS)
within the cell, leads to the phosphorylation of Nrf2–Neh2 domain
at ser-40 residue, which is mediated by protein kinase C (PKC). PKC
are the protein kinase phosphorylating enzymes of serine–threonine
mediated signal transduction pathway. Phosphorylation of Nrf2 S40
was reported to be important for the complete release of Nrf2 from
Keap1 in the cytoplasm [ 52 ]. Haung et al. [ 53 ] demonstrated that PKC
phosphorylated the wild type Nrf2 and promoted its dissociation from
Keap1; while the Nrf2-S40A mutant did not show any dissociation.
In an experimental study, Niture et al. [ 54 ] concluded that PKC- δ isa major isoform and phosphorylating enzyme of PKC which acted on
ser-40 residue of Nrf2–Neh2 domain and played a crucial role in the
release of Nrf2 from Keap1. 
Once Nrf2 gets released from its suppressors (Keap1 as well as
the ubiquitin machinery Cul3–E3 ligase complex), the Nrf2 translo-
cates towards nucleus [ 55 ]. For nuclear entry, murine Nrf2 possess
two novel nuclear localization sequence (NLS) which were located
between 42 and 53 amino acid sequence at N-terminal and the other
between 587 and 593 amino acids residues at C-terminal [ 56 ]. The
Nrf2 NLS motifs determined the entry into the nucleus through im-
portin α5 and β1 receptor homology. Therefore, NLS motif on Nrf2
provided a nuclear entry to the Nrf2 and facilitated the ARE-mediated
gene expression in response to oxidative stress. Deleted or mutated
NLS motif failed to localize the induced Nrf2 into the nucleus, as
identiﬁed by using immunoﬂuorescence and immunoblot studies in
HepG2 cells. This study further described that wild type Nrf2 NLS
(fused with green ﬂuorescence protein, GFP) showed translocation
and accumulation of Nrf2 into the nucleus within 15 min of tert-
butyl hydroquinone (t-BHQ) treatment while the mutated Nrf2 NLS
showed diminished expression of ﬂuorescence [ 57 ]. Later on, Kasper
et al. [ 58 ] reported that under oxidative / electrophilic stress condi-
tions, Nrf2 was the ﬁrst one to enter into the nucleus (early response)
within 15 min of oxidative stress and turned on the cytoprotective
antioxidant response [ 57 , 58 ]. Thereafter, when redox homeostasis
was achieved, the Keap1 entered the nucleus gradually (delayed re-
sponse), which further mediated Nrf2 export and degradation. These
sequential mechanisms could be cell speciﬁc or they could be guided
by external factors, which may change or modify the interaction of
Nrf2–Keap1 during nucleo-cytoplasmic shuttling [ 59 –62 ]. Under ox-
idative stress conditions, the KPNA6 importin slows down the Keap1
836 Anuranjani, M. Bala / Redox Biology 2 (2014) 832–846 
Fig. 2(B). Diagrammatic presentation to explain the domains and their sequence pattern in Keap1 dimer structure. The structural conformation of Keap1 exists in the form of 
β-sheets. (b) At N-terminal BTB / POZ domain of Keap1 binds to another homomer from other N-terminal BTB / POZ domain, stabilizes the dimer structure and modiﬁes the Kelch 
domains to hold Nrf2 at C-terminal, so that Cul3–Rbx–E3 ligase component degrades the Nrf2 under normal / unstressed conditions. Under normal redox conditions, BTB / POZ 
domain of Keap1 performs two functions mainly i.e. (i) formation of Keap1 homodimers (ii) provide binding site to Cul3–E3 ubiquitin ligase which regulates Nrf2 degradation. 
C151 residue (located at Cul3–E3 ligase binding site on BTB / POZ) is necessary to provide active binding site to the ubiquitin complex. (c) C273 and C288 residues present on IVR 
region are essential to maintain E3-ligase ubiquitin activity. (d) The C-terminal Kelch repeats physically attaches with Neh2 domain of Nrf2 [ 43 ]. 
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 mport into the nucleus to facilitate maximization of the early re- 
ponse of Nrf2–ARE genes [ 63 ]. Keap1 acts as a molecular switch to 
egulate the Nrf2 movement between the nucleus and cytoplasm. 
eap1–Cul3–E3 complex mediates Nrf2 nuclear export and its degra- 
ation into the cytosol. Fig. 3 schematically presents regulation of 
eap1-Nrf2-ARE pathway. 
The Nrf2 export from nucleus is a two-step mechanism. First, the 
etachment of Nrf2 from ARE takes place and it blocks the further 
ynthesis of antioxidant proteins and detoxiﬁcation enzymes. Next, it 
equires the Nrf2 NES activation and interaction with Keap1 directed 
rm1 / exportin. Under oxidative stress conditions (in earlier and de- 
ayed response), glycogen synthase kinase-3 beta (GSK-3 β), a serine / 
hreonine protein kinase located on cellular membrane played an im- 
ortant role in Nrf2 nuclear export. The GSK-3 β acted as upstream 
egulator for Nrf2 tyr568 phosphorylation and detachment of Nrf2 
rom ARE [ 64 –66 ]. This mechanism is summarized in Fig. 4 . 
The other mechanism of Nrf2 export relies on Nrf2 NES TA acti- 
ation [ 60 , 67 ]. According Sun et al. [ 63 ], the NES motifs present on
rf2 and Keap1 triggered the release of complex out of the nucleus. 
 point mutation on two of the Nrf2 NES and one Keap1 NES by the 
ubstitution of alanine in place of hydrophobic amino acids showed 
hat neither Nrf2 nor Keap1 were exported out of the nucleus. NES 
eap1 mutant showed stronger inhibition in comparison to the two 
ES of Nrf2. The immunoﬂuorescence staining explained a likely re- 
ponse in which Keap1 NES played important role in the export of 
eap1–Nrf2 complex from the nucleus. The study showed Keap1 NES 
ad more important role than Nrf2 NES. Therefore, Keap1 in associ- 
tion with Nrf2 was exported out of the nucleus. In the cytoplasm, 
rf2 was further ubiquitinated and degraded via a Keap1–Cul3–E3 ligase complex under the normal redox state of cell [ 24 , 63 , 68 ]. The 
export of Nrf2 from nucleus to cytoplasm is important because exces- 
sive accumulation of Nrf2 within the nucleus causes overexpression 
of antioxidants which favour the growth and chemo-resistance of 
tumour cells. [ 69 ]. 
Modiﬁcation of Nrf2-ARE pathway 
It was reported that the overexpression of Nrf2 caused resistance 
to apoptosis in the tumour cells after chemotherapeutic drug treat- 
ment [ 70 , 71 ]. A study by Niture and Jaiswal [ 70 , 72 ] on mouse hep-
atoma (Hepa-1) and hepatoblastoma (HepG2) cells explained the 
fact, that t-BHQ induced Nrf2 overexpression lead to the induction 
of B-cell lymphoma-2 protein (Bcl-2) gene expression. Bcl-2 protein 
family regulates several anti-apoptotic factors such as Bcl-2, Bcl-xL, 
and Bcl-w. The expression of anti-apoptotic factors down regulated 
the cellular apoptosis and induced drug resistance. It was reported 
that the promoter region of Bcl-2 gene comprised antioxidant re- 
sponse element (AREr3) between nucleotides −3148 and −3140 on 
reverse band. The t-BHQ induced Nrf2 got bound to the AREr3 pro- 
moter region and activated Bcl-2 gene expression which reduced cel- 
lular apoptosis and increased cell survival. Later, Seibens et al. [ 73 ] 
studied macrophages induced oxidative stress in colonic NCM460 
cells. They reported that increased inﬂammation led to increased, 
Nrf2-dependent proteasome activity of oxidized proteins present in 
the nucleus. Also, overexpression of Nrf2 activation inhibited death 
ligand i.e. TNF-related apoptosis inducing ligand (TRAIL) but at the 
same time, it activated anti-apoptotic protein cIAP1. Another study 
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Fig. 3. Diagrammatic presentation of regulation of Keap1-Nrf2-ARE pathway. Under the oxidative stress condition, disruption of the Keap1 dimer occurs due to the mutation on 
ser-104 residue of BTB / POZ domain of Keap1 [ 59 ]. In turn protein kinase C phosphorylates Nrf2–Neh2 domain at ser-40 residue, which is essentially required for complete release 
of Nrf2 from Keap1 dimer into the cytoplasm [ 52 ]. The free form of Nrf2 showed disabled NES motifs and activation of NLS. The NES TA , which was disabled due to the sulphhydryl 
modiﬁcation on C183 residue, caused steric hindrance upon interaction with Crm1 / exportin [ 60 ]. The NES ZIP motif, however, turned off due to the masking of export sequences 
when Nrf2 heterodimerize with small Maf proteins within the nucleus [ 61 ]. NLS motif on Nrf2 is recognized by the importin α5 and β1 receptor homology on nuclear membrane 
for entering into the nucleus [ 57 , 61 ]. Within the nucleus, core sequence (5 ′ -TGACnnm GC-3 ’ ) of cis-acting regulatory element ARE binds to the Nrf2 (5 ′ -TGA(C / G)TCA-3 ′ ) with a 
complementary sequence homology. The Nrf2–ARE regulates transcription of antioxidants and phase II detoxifying enzymes which in turn play important role in cellular defence. 
Upon achieving redox homeostasis, the Keap1 independently enters into the nucleus via the receptor importin alpha-7 (also known as KPNA6) recognized by the C-terminal Kelch 
repeats having NLS motifs. The nuclear Keap1 mediates Nrf2 dissociation from ARE. Subsequently, Nrf2 NES activation directs the exporting of Keap1–Nrf2 complex out of the 
nucleus via Crm1 / exportin [ 62 ]. The Keap1–Nrf2 complex bind to the Cul3–E3 ligase ubiquitin core complex within the cytosol resulting in further ubiquitination and degradation 
of Nrf2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 showed that there was apoptotic inhibition in cerebral cortical neu-
rons which displayed overexpression of Nrf2 due to oxidative stress
caused by ethanol. The ethanol toxicity caused depletion of GSH and
subsequently cell death in the developing cerebral neurons [ 74 ]. 
The Nrf2-ARE pathway overexpression was reported to be respon-
sible for altering multidrug resistance associated protein (MRP) 1–6
transporters target genes [ 75 ]. The MRPs are responsible for decreas-
ing the drug susceptibility by reducing intracellular accumulation of
drugs in association with GSH. The overexpression of Nrf2 caused
increased level of GSH within the nucleus, which lead to increased
efﬂux of the MRPs transporters, thereby preventing the accumulation
of chemotherapeutics drugs inside the cell [ 76 ]. 
MRN complex: DNA damage response 
The recognition of DNA DSBs readily initiates the DNA damage
response (DDR) by activating the DNA repair protein kinases and cell
cycle regulatory proteins. DNA DSBs repair is broadly classiﬁed intonon-homologous end joining (NHEJ) and homologous recombination
(HR) repair. The NHEJ is an error-prone DNA DSBs repair process in
which DNA ends are re-joined in a simple manner without any re-
quirement of sequence homology [ 77 ]. HR is relatively an error-free
repair pathway that is directed by extensive homology and recom-
bination of DNA strands. HR is predominantly accurate, because the
sister chromatid is utilized as the invading donor. The error free DNA
repair pathway ensures maintenance of DNA structural integrity. The
Mre11-Rad50-Nbs1 (MRN / homologous to MRX in yeast where “X”
stands for Xrs2) is a highly conserved protein complex among mam-
malian species showing vital importance in DNA DSBs end processing,
repair mechanism and cell cycle checkpoints control [ 78 ]. The proper
association of MRN subunits (complex form) around the damaged
γ-H2AX foci is essential for DNA DSB recognition and initiation of
repair by NHEJ or HR pathways [ 79 –81 ]. The MRN complex, com-
prised of two Mre11 subunits, has terminal DNA binding domains for
attachment with damaged DNA γ-H2AX foci, and sequence comple-
mentary for the association with two molecules of Rad50. Another
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Fig. 4. A mechanism showing tyrosine kinase receptor induced regulation of Nrf2 nuclear–cytoplasmic shuttling under redox homeostasis conditions. The cytoplasmic signal 
transduction (blue) of GSK3 β regulates the Nrf2 phosphorylation and its transfer from nucleus (pink) to cytoplasm. The GSK3 β acts as an upstream regulator for Src-family 
kinases which include Fyn / Src / Lyn / Fgr kinases. Gradually, when cell achieves the redox homeostasis state, the activated GSK-3 β phosphorylates Fyn kinase at threonine residue 
to promote nuclear localization of Fyn. The phosphorylated Fyn kinase further phosphorylates Nrf2 Try568 residue within the nucleus, which result in Nrf2 separation from ARE 
leading to export / degradation of Nrf2 from the nucleus. On the other hand, during early response of oxidative stress, PKC mediated phosphorylation of Nrf2 at ser-40, inactivated 
the GSK3 β due to the phosphorylation at ser-9 residue and only basal level of Fyn kinase expression was detected. The Fyn kinases were auto-phosphorylated at Tyr213 residue 
via unknown tyrosine kinase signalling. The Tyr-213 phosphorylated Fyn exported from nucleus via Crm1-exportin so that Nrf2–ARE expression was enhanced in early response 
to oxidative stress conditions [ 65 ] Fyn acted as an inhibitor of Nrf2–ARE complex at a later stage of oxidative stress when cell is trying to attain a redox homeostasis (delayed 
response). 
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cubunit, Nbs1or nibrin / p95, is a 95 kDa and 754 amino acid protein 
ragment present on chromosome no. 8q21. Nbs1 is of vital impor- 
ance in MRN complex association on radiation induced foci (RIF) in 
he nucleus. 
The MRN complex is amenable to modiﬁcation by sub-lethal doses 
f low LET IR. In Saccharomyces cerevisiae as well as in human lympho- 
ytes, the modiﬁcation caused by 60 Co gamma-radiation dose which 
ills ≤10% population (sub-lethal dose), can enhance the radiation in- 
uced radio-resistance to the lethal doses ( ≥LD 50 ) of 60 Co γ-radiation 
 82 ]. The targeted disruption of Nbs1 subunit caused lethality in mice 
t early embryonic stage primarily due to the Nijmegen breakage 
yndrome [ 83 ]. On the other hand, the conditional targeted disrup- 
ion of mRad50 and Mre11 showed high IR sensitivity and impaired 
he repair of DNA DSBs leading to mutations, genetic instability and 
umour progression in mice embryonic stem cells [ 84 , 85 ]. Following 
NA DSBs, the MRN complex moved from cytoplasm to nucleus to 
ind to the affected DNA [ 86 –89 ]. Fig. 5 presents the MRN complex 
ecruitment towards radiation induced DNA damage γ-H2AX foci and 
nitiation of downstream events. 
The MRN recruits active ATM dimer inside the nucleus and asso- 
iates with the RIF. The human ﬁbroblast cells exposed to IR (0.5 Gy) showed phosphorylation of the active ATM within 5 min, which was 
maintained till 24 h onto the damaged site [ 90 –93 ]. The activated 
ATM phosphorylated checkpoint kinase 2 (Chk2) protein which fur- 
ther regulated the activation of protein kinase of molecular weight 
53 kDa [called p53 (tumour suppressor gene)] and cdc25C, cell cycle 
proteins. The cdc25C halted the cell cycle at the G2–M phase [ 94 ]. 
The immunoblot study of Hirao et al. [ 95 ] reported the absence of 
p53 induction in CHK2 −/ − DNA damaged thymocytes compared to 
wild type cells after 5 Gy of gamma-irradiation. Similar results were 
found in activated CHK2 −/ − T cells (5 Gy) and CHK2 −/ − primary MEFs 
(10 Gy irradiation). The apoptotic protein, Bax level was also increased 
in wild type cells, indicated the Chk2-p53 mediated apoptosis at the 
G2 / M phase. There are other studies to show that during DDR, ATM 
can directly phosphorylate p53 protein at multiple sites i.e. ser-15, 
ser-46 etc. [ 96 ], to trigger the G1 arrest irrespective of the presence 
of Chk2. The Chk2 is dispensable for p53 mediated p21induction in 
the G1–S phase of cell cycle. Quantitative reverse transcriptase-PCR 
analysis after 5 Gy gamma irradiation to wild type and p53 −/ − MEFs 
demonstrated that upregulation of p21 mRNA expression was absent 
in p53 −/ − MEFs but was observed in wild type MEFs [ 97 ]. Further, 
ﬂow cytometer study showed that p53 −/ − MEFs cells failed to show 
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Fig. 5. Schematic presentation of MRN complex recruitment towards radiation induced DNA damage foci. The MRN complex initiates a cascade of phosphorylation events, which 
activate DNA damage response (DDR) protein kinases for cell cycle arrest during repair. Ionizing radiation induced foci (RIF) on DNA generated due to the phosphorylation of 
conserved histone H2A variant, H2AX at serine 139 residue [ 86 ]. The phosphorylated form γ-H2AX covered the large region of chromatin including the damaged site per DNA 
within the few minutes and reached at peak in 30 min of IR exposure [ 87 ]. The C-terminal of NBS1 101 amino acid sequences are the strongly interacting sites for Mre11 as well 
as are the sites for attachment of ataxia telangiectasia mutant (ATM), an another DNA repair protein [ 88 ]. The MRN mediated DNA end processing also generates small ssDNA 
oligomers due to the endonuclease activity of Mre11 subunit [ 89 ]. Under normal conditions, ATM dimer composition (inactive form) exits within the cytoplasm whereas DDR 
initiate autophosphorylation at ser-1981 residue of ATM. In reverse, ATM phosphorylated the MR bound NBS1 subunit at ser-343 residue. The phosphorylation events form an 
active MRN–ATM complex. The MRN–ATM complex binds to the RIF to stimulate the downstream DDR pathway. At the same time, several other protein kinases also are recruited 
towards RIF i.e. mediator of DNA damage CHK1 (MDC1), binding protein1 (53BP1) which directly link up with the γH2AX foci. The phosphorylated ATM is attached with FHA 
domain of MDC1 protein that primarily holds the γ-H2AX with its other domain BRCT. The activated ATM phosphorylated the cell cycle checkpoint 2 (Chk2) at Ther-68 residue. The 
phosphorylated Chk2 mediated cdc25C phosphorylation at ser-216 residue inhibited the cdk1 activity and thus arrested the cell cycle at the G2 / M phase. ATM-Chk2 association 
also phosphorylate ser-20 residue of p53, thereby activating the apoptosis of severely injured unrepaired DNA. ATM mediated direct phosphorylation of p53–p21 complex at 
multiple sites helps in DNA repair and cell cycle arrest at the G1 phase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 G1 cell cycle arrest. The stabilization of p53–p21 complex therefore,
plays an important role during DDR. Signal transduction of DDR was
understood to be responsible for directing the role of p53 in various
events such as inducing cell cycle arrest, repair or apoptosis [ 98 , 99 ]. 
Inﬂammation and immunomodulation: HMGB1 pathway 
Under increased oxidative stress, there is increased accumula-
tion of unrepaired intracellular damage which causes the cells to
undergo either programmed cell death (i.e. apoptosis) or necrosis
(a complete disintegration of cellular components which lead to to-
tal cell lysis). The apoptosis is an active, energy consuming suicidal
collapse of group of cells. The damaged apoptotic cells are engulfed /
phagocytosed by macrophages and therefore, do not cause inﬂamma-
tion. On the other hand, severely damaged cells that are unable to form
phagosome primarily due to lack of energy (ATP), undergo necrosis
and passively disintegrate the intracellular components, which in turn
augment inﬂammation. The susceptibility of individual cell towards
necrotic cell death depends upon a number of factors such as ratio
of ROS level to antioxidant level, energy loss, failure in repair process
of damaged DNA lesions, and irreversible disrupted permeability ofcellular membrane [ 100 ]. The high mobility group box 1 (HMGB1)
protein is a conserved non-histone DNA chromatin binding nuclear
protein that resides in the nucleus of almost every nucleated cell at
quiescent stage. HMGB1 is loosely bound to chromatin and is pas-
sively released out of nucleus from the necrotic cells but not from
the apoptotic cells. Structural details of chromatin bound HMGB1 is
shown in Fig. 6(A) . 
The active secretion of HMGB1 by the activated macrophages and
monocyte cells was reported to occur in response to the inﬂamma-
tory stimuli of various cytokines i.e. TNF- α, IL-1, IFN- γ [ 101 , 102 ]. The
extracellular HMGB1 molecule in association with the receptor for
advanced glycation end-products (RAGE) stimulated the induction of
NF-kB / ERK pathway. The active phosphorylated form of NF-kB, trans-
duced the signal for the release of loosely bound chromatin HMGB1
from nucleus to extracellular space (via lysosomal secretion from the
cytoplasm) by deactivating histone deacetylate (HDAC) enzyme [ 103 ].
Under the state of oxidative stress, caused by whole body exposure
of mice to lethal dose (10 Gy) of radiation, the simultaneous active
and passive secretion of HMGB1 was reported, which acted as death
associated molecular pattern (DAMP) molecule and further enhanced
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Fig. 6(A). Detailed structure presentation of chromatin bounded nuclear HMGB1 molecule. Under normal conditions, chromatin bound HMGB-1 nuclear export and its pro- 
inﬂammatory activity is repressed by histone deacetylate enzyme (HDAC-1) in the nucleus. The increased oxidative stress conditions leads to extracellular release of reduced form 
of acetylated HMGB1 by necrotic cell death, which acts as inﬂammatory cytokine. 
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 he production of pro-inﬂammatory cytokines leading to acute in- 
ammation and tissue damage. The TNF- α expression in irradiated 
ice was observed as soon as 2 h after irradiation and remained sig- 
iﬁcantly high till 48 h after irradiation. HMGB1 level was maximum 
t 8 h after irradiation. This study further investigated the effects of a 
adioprotective extract (coded as SBL-1), prepared from leaves of Hip- 
ophae rhamnoides L. (common name Seabuckthorn, F. Elaegnaceae ) 
 104 ] and had many antioxidants [ 105 ]. Treatment with SBL-1, 30 min 
rior to irradiation, showed delayed release of HMGB1 (peak at 16 h) 
s well as normalization of TNF- α as early as 16 h after irradiation 
 106 ]. Treatment of C3H / HeJ mice with endotoxin LPS, stimulated 
acrophages and caused instant secretion of pro-inﬂammatory cy- 
okines (TNF- α, IL-1); but the secretion of HMGB1 in serum started 
nly after 6–8 h which persisted till 32 h . The secretion of HMGB1 
urther increased the level of pro-inﬂammatory cytokines and there- 
ore, was considered to be responsible for lethality or sepsis [ 107 , 108 ].
he persistent level of secreted extracellular HMGB1 were reported 
n several chronic inﬂammatory disorders i.e. autoimmune disease 
 109 ] arthritis [ 110 ], ischemia and reperfusion injury etc. [ 111 , 112 ]. 
HMGB1 also has contribution in the regenerative and survival 
esponse. The secreted extracellular HMGB1 has all thiols cysteine 
esidues in the reduced state. The increase in oxidative stress oxi- 
izes the secreted HMGB1 cys residues partially or completely, in a 
ime dependent manner. Change in the redox state of HMGB1 is pro- 
osed to be responsible for alteration in its function as reported in the 
ollowing studies. The NMR-based study showed that the half-life of 
educed form of extracellular HMGB1 (all thiols) in serum and saliva 
ample of human was found to be approximately 17 min. Under in- 
reased oxygen pressure, the oxidized HMGB1 (disulphide) showed 
tronger peaks in serum at 50 min. In the same study, the prostate can- 
er cultured cells (PC-3M) showed half-life of HMGB1 (all thiols) up to 
 h [ 113 ]. The expression of oxidized HMGB1 was responsible for the promotion of mesoangioblast cells migration and proliferation across 
the endothelial barrier in murine D16 inﬂamed cells demonstrating 
that the oxidized HMGB1 was involved in the tissue regeneration 
[ 114 ]. The HMGB1–RAGE signalling plays a dual role of destruction or 
reconstruction at the damaged tissue site. Fig. 6(B) shows this infor- 
mation, which is based on a number of studies [ 114 –120 ]. 
Angiogenesis maintained the inﬂammatory state by transporting 
inﬂammatory cells to the site of inﬂammation and supplying nutri- 
ents and oxygen to the proliferating inﬂamed tissue [ 121 ]. Activated 
macrophages and its secreted cytokines are the major source for the 
activation of angiogenic factors. Some direct factors that regulate the 
process of angiogenesis are granulocyte-macrophages colony stim- 
ulating factor (GM-CSF) [ 122 ], basal ﬁbroblast growth factor (bFGF), 
and vascular endothelial growth factor (VEGF) [ 123 , 124 ]. The other 
immunological mediators are classiﬁed as TNF- α, IL-16, IL-8, and 
prostaglandins (PGE 2 ) which also act as angiogenic factor in vivo 
[ 121 ]. 
“TWEAK” [tumour necrosis factor (TNF) weak inducer of apopto- 
sis] is a signiﬁcant inducer of pro-inﬂammatory cytokines secreted 
by inﬂamed macrophages and vascular smooth muscle cells (VSMC). 
It plays many biological roles such as cell differentiation, caspase de- 
pendent apoptosis, NF-kB mediated cell proliferation, and angiogene- 
sis. In cultured human, mouse, rat, primary cells or immortalized cell 
lines, the TWEAK was shown to regulate cell proliferation [ 125 , 126 ], 
migration [ 127 , 128 ], survival [ 129 ], and necrosis [ 130 ]. TWEAK is a
cell surface associated type II transmembrane protein. TWEAK mRNA 
is widely expressed in a variety of tissues and cell types including 
macrophages, astrocytes and microglia, thyroid lineage precursors, 
monocytes and T cells, activated monocytes, dendritic cells, and NK 
cells and also in most major organs viz. heart, skeletal muscle, kid- 
ney and brain [ 126 , 131 –136 ]. TWEAK posses speciﬁc binding site on 
ﬁbroblast growth factor receptor (also called Fn 14). Tweak receptor 
Anuranjani, M. Bala / Redox Biology 2 (2014) 832–846 841 
Fig. 6(B). Schematic presentation showing the HMGB1 release from the nucleus due to the necrotic cell death under oxidative stress conditions. The HMGB1 secretion enhanced 
the inﬂammation and initiated a cascade of signal transduction for the release of proinﬂammatory cytokines. The secreted extracellular HMGB1 molecule structurally consists 
thiols cysteine residues in its DNA binding A and B domains. The reduced form of HMGB1 acts as chemoattractant for leukocytes recruitment at the inﬂamed site. Under oxidative 
stress conditions, extracellular HMGB1 is readily oxidized and primarily forms disulphide linkage between adjacent cysteine molecules 23 and 45 on A-box. The disulphide form of 
HMGB1 actively stimulates the proinﬂammatory cytokine production via binding to RAGE receptor [ 114 , 116 ]. The HMGB1 is itself considered as DAMP molecule because it forms 
highly inﬂammatory complex in association with ssDNA, necrotic cell debris, IL-1 β etc. The secreted HMGB1 directly act onto the activated inﬁltrated immune cells which reach 
immediately at the necrotic site. The primary inﬁltered immune cells i.e. neutrophils, macrophages, monocytes possess cell surface receptor for advanced glycation end products 
(RAGE) speciﬁc for HMGB1 binding [ 117 ]. RAGE is a transmembrane receptor protein mainly present on immunoglobulin superfamily. RAGE–HMGB1 complex contributes to 
the induction of proinﬂammatory genes and lethal shock signalling [ 119 ]. The complex triggers the activation of NF-kB, ERK, PI3 / AKT signalling and stimulates the gene expression 
of various IL-6, TNF- α, macrophages inﬂammatory proteins (MIP) 1 α and 1 β proteins etc. [ 118 , 119 ].Cumulative effect of continuous rising oxidative stress as well as of tissue 
damage leads to the irreversible complete oxidation of all cys residues of HMGB1 A and B boxes. The sulphonic (oxidized) form of HMGB1 modiﬁes its functional activity i.e. 
abrogates pro-inﬂammatory cytokine production and chemoattractant property. The oxidized HMGB1 promotes the tissue regeneration and survival response. It was demonstrated 
invivo and in vitro that complete oxidation of HMGB1 acted as a feedback mechanism to counter the inﬂammatory activity and tissue damage [ 114 , 115 ]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (TweakR) or Fn 14 is a type-I transmembrane protein that activates
upon interaction with TWEAK and leads to NF-kB mediated signalling
in cell differentiation and proliferation mechanism [ 137 ]. 
Under normal conditions inactive TWEAK is present in the vascular
tissue. The cell surface receptor Fn 14 is expressed on inﬂammatory or
injured cells [ 138 , 139 ]. Moreno et al. [ 140 ] demonstrated that TWEAK
increased HMGB1 mRNA expression in cultured THP-1 monocytes.
The RT-PCR study explained that expression of HMGB1 mRNA was
dependent on the concentration of TWEAK and the treatment time.
The TWEAK induced secretion of HMGB1 from nucleus to cytoplasm
was blocked upon treatment with anti-Fn 14 antibody. It was inferred
that presence of Fn 14 on inﬂammatory macrophages / monocytes was
essential for the secretion of HMGB1 into the cytoplasm. In another
study, it was reported that TWEAK-Fn14 upregulation augmented the
uncontrolled proliferation of liver cells in IR exposed mice. However,
if mice were treated with radioprotective leaf extract of Hippophae
rhamnoides (coded as SBL-1) [ 104 ] before irradiation (10 Gy), the
Tweak-Fn 14 expression in liver cells was altered to support liver re-
generation in the irradiated mice [ 141 ]. In 1999, Lynch et al. reported
that soluble TWEAK could stimulate angiogenesis when delivered into
the rat cornea (50–200 ng dosage per eye). Other studies suggested
 
 that TWEAK-Fn14 signalling regulated the pathophysiological angio-
genesis in vivo at the damage site [ 125 , 139 , 142 ]. An experimental
study demonstrated that ﬁbroblast growth factor-2 (FGF2) promoted
angiogenic activity in mouse cornea was partially inhibited by TweakR
antagonist. The expression of TWEAK-Fn14 signalling promoted an-
giogenic activity of FGF-2, VEGF etc., at the inﬂamed tissue site [ 143 ]
. In silico studies showed that blocking of the natural ligand binding
site of Fn 14 with the antioxidants (gallic acid, rutin, quercetin and
genistein but not with ellagic acid) could prevent the uncontrolled ex-
pression of TWEAK–Fn14 complex and may contribute to prevention
of radiation induced neoplasms [ 144 ]. 
Crosstalk between Nrf2-ARE, DDR and HMGB1 pathways 
Under IR induced oxidative stress conditions, Nrf2-ARE acts as
a promising antioxidants cytoprotective pathway which contributes
signiﬁcantly in relieving the cell from excess of free radicals and ROS,
ultimately helping in repair of IR damage and therefore, cell survival.
As discussed in previous sections based on several studies, DDR is
an essential requirement for severely injured cells to prevent the
apoptosis or necrotic cell death [ 145 ]. Although direct evidence is
lacking, a number of studies collectively suggest that the Nrf2-ARE
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Fig. 7. Proposed crosstalk between the Nrf2-ARE pathway, HMGB1 and DNA damage response (DDR). The increase in oxidative stress causes multiple effects such as inﬂammation, 
DNA damage, and immunosuppression. The Nrf2-ARE pathway regulates time kinetics of HMGB1 level. The modiﬁcation of oxidative stress by Nrf2-ARE also inﬂuences DDR. The 
MRN complex activated as a part of DDR may further augment p53. Under oxidative stress conditions the p21 interacts with Neh2 domain of Nrf2. During DDR, MRN complex 
activates p53, which in turn interacts with p21. The direct evidence of p21 mediated interaction of Nrf2 and MRN is lacking. The interaction of Nrf2 with p53-Chk2 is also not clear 
from the available literature. 
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antioxidant pathway has a role in DDR response and the dual ac- 
ion of p21 is indicated. The p21 acts as cyclin dependent cell cycle 
egulatory protein kinase. On recognizing DNA DSBs, p21 mediates 
he cell cycle arrest at the G1 phase in order to allow the time for 
NA repair [ 146 ]. Further, the p21 is also involved in activation of 
rf2-ARE signalling pathway. Structural studies demonstrated that 
he Nrf2 Neh2 domain was associated with the phosphorylated p21. 
he p21 154 KRR sequence at C-terminal showed conjugation with the 
rf2 N-terminal DLG 29 and ETGE 79 motifs which implies that p21 gets 
hysically bound to the Nrf2 Neh2 domain (a competitive binding site 
f Keap1) [ 147 ]. The Nrf2-p21 complex expression into the nucleus 
uggested the ﬁrst line of defence against oxidative stress induced 
NA damage. The p21 was shown to enhance the survival response 
n HCT116 Nrf2 + / + cells but not in HCT116 Nrf2 −/ − mouse em- 
ryonic ﬁbroblasts (MEFs) after treatment with H 2 O 2 [ 148 ]. Reddy et 
l. [ 149 ] examined the Nrf2 −/ − primary epithelial cultured cells and 
emonstrated the reduction in GSH level with increase in the ROS 
oncentration. They also reported the generation of DNA lesions in 
rf2 −/ − cells, but not in wild type, and GSH treated Nrf2 −/ − cells by 
sing positive FITC-conjugated avidin staining and TUNEL staining. 
urthermore, the DNA DSBs and cellular apoptosis were signiﬁcantly 
bserved in HEK293 cells upon whole body irradiation to 60Co- γ rays 
4 Gy). The upregulation of Nrf2-ARE pathway on pre-treatment with 
esquiterpene, Zerumbone ( Zingiber Zerumbet Simith) at 5–20 μM 
oncentrations, showed attenuation of the IR induced DNA DSBs and 
mproved cell viability in a dose dependent manner [ 150 ]. The 137Cs 
rradiated (0.72 Gy / min of total 1 Gy) 3WT murine lymphocytes cell 
ine showed DNA DSBs lesions which induced upregulation of Nrf2 at 
 h after irradiation. The peak was achieved at 4 h and recovered to the 
asal level at 8 h after irradiation. Therefore, IR induced DNA DSBs 
enotoxicity can be rescued by the activated Nrf2-ARE antioxidant 
athway [ 151 , 152 ]. 
The Nrf2-ARE pathway activation and inducible expression of cy- 
oprotective antioxidants showed marked reduction in the inﬂam- 
atory cytokines production. It was reported that H 2 O 2 cytotox- 
city in human aortic endothelial cells (HAECs) induced Nrf2–ARE 
ctivation by AdNrf2 transfection. The activated Nrf2 enhanced the GSH biosynthesis as well as reduced the TNF- α induced monocyte 
chemoattractant protein-1 (MCP-1) level by approximately 70%, as 
compared to the Nrf2 −/ − human aortic endothelial cells. The study 
also demonstrated the suppression of vascular cell adhesion molecule 
(VCAM-1) protein and thus, inhibited the TNF- α induced inﬂamma- 
tion response in HAECs [ 153 –155 ]. Some experimental studies also re- 
vealed the Nrf2-ARE pathway interaction with the inhibitory regula- 
tion of HMGB1 secretion from macrophages / monocytes cells. Kawa- 
hara group [ 156 ] found that in LPS stimulated murine macrophage 
264.7 cells, the secretion of inﬂammatory HMGB1 was inhibited upon 
treatment with natural triterpenoid. It was illustrated that herbal 
preparation of Ume extract (an extract of Prunus mume Sieb. et Zucc. ) 
induced Nrf2 activation and lead to increase HO-1 gene expression in 
dose dependent manner. The Western blotting analysis conﬁrmed the 
induced Nrf2 / HO-1 expression and strong inhibition of the HMGB1 
secretion from macrophages 264.7 cells. In another study, ethanol 
extract of ﬂower “Proteus vulgaris var. lilacina ” (EEPV) was used to 
induce the Nrf2 mediated HO-1 gene expression which inhibited the 
secretion of HMGB1 in LPS stimulated macrophages 264.7 cells in 
dose dependent manner. To check Nrf2 / HO-1 mediated inhibition 
of HMGB1, siNrf2 transfected macrophages cells were treated with 
EEPV. They found the reduction in HO-1 gene expression as well as 
increased secretion of HMGB1 protein in Western blot analysis. Thus, 
the study revealed that the induction of Nrf2 by EEPV was responsi- 
ble for the HO-1 upregulation and inhibition of inﬂammatory HMGB1 
secretion [ 157 , 158 , 159 ]. Fig. 7 proposes the interlinking of Nrf2-ARE 
pathway with DDR via modiﬁcation of different cellular events and 
signalling pathways. 
Conclusion and future perspectives 
IR induced radiation injuries and oxidative stress show serious 
clinical consequences and multiple pathophysiological conditions 
which need careful attention and in depth study. The damaged tissue 
architecture, inﬂammation and immune modulation are some of the 
key factors which inﬂuence many molecular and cellular pathways 
ultimately affecting the survival response. An ideal medical radiation 
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 countermeasure should logically provide protection against multiple
pathophysiological conditions experienced by an organism after radi-
ation exposure. The mechanism of IR induced oxidative stress, DDR,
inﬂammation etc., therefore, need understanding in greater depth.
The Nrf2-ARE pathway favours the survival response of an organ-
ism by detoxifying ROS and free radical species, controlling cell cycle
regulatory protein for DDR and by inhibiting the production of inﬂam-
matory cytokines via multiple pathways. This review summarizes the
regulatory mechanism of Nrf2-ARE pathway and its inﬂuence on MRN
complex and HMGB1 under IR induce oxidative stress conditions. Be-
sides academic interests, this study can be of help in designing novel
therapeutics strategies and approaches to counter radiation injuries. 
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